• 1
    Howard RA,Gilbert ES,Chen BE,Hall P,Storm H,Pukkala E,Langmark F,Kaijser M,Andersson M,Joensuu H,Fossa SD,Travis LB. Leukemia following breast cancer: an international population-based study of 376,825 women. Breast Cancer Res Treat 2007; 105: 35968.
  • 2
    Renella R,Verkooijen HM,Fioretta G,Vlastos G,Kurtz J,Sappino AP,Schafer P,Neyroud-Caspar I,Bouchardy C. Increased risk of acute myeloid leukaemia after treatment for breast cancer. Breast 2006; 15: 61419.
  • 3
    Curtis RE,Boice JD,Jr,Stovall M,Bernstein L,Greenberg RS,Flannery JT,Schwartz AG,Weyer P,Moloney WC,Hoover RN. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 1992; 326: 174551.
  • 4
    Rubino C,De Vathaire F,Diallo I,Shamsaldin A,Le MG. Increased risk of second cancers following breast cancer: role of the initial treatment. Breast Cancer Res Treat 2000; 61: 18395.
  • 5
    Smith RE,Bryant J,DeCillis A,Anderson S. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience. J Clin Oncol 2003; 21: 1195204.
  • 6
    Chaplain G,Milan C,Sgro C,Carli PM,Bonithon-Kopp C. Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study. J Clin Oncol 2000; 18: 283642.
  • 7
    Andersen MK,Christiansen DH,Jensen BA,Ernst P,Hauge G,Pedersen-Bjergaard J. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992. Br J Haematol 2001; 114: 53943.
  • 8
    Sellick GS,Catovsky D,Houlston RS. Familial chronic lymphocytic leukemia. Semin Oncol 2006; 33: 195201.
  • 9
    Jonsson V,Houlston RS,Catovsky D,Yuille MR,Hilden J,Olsen JH,Fajber M,Brandt B,Sellick G,Allinson R,Wiik A. CLL family ‘Pedigree 14’ revisited: 1947–2004. Leukemia 2005; 19: 10258.
  • 10
    Schottenfeld D,Fraumeni JF. Cancer epidemiology and prevention. New York: Oxford University Press, 2006.
  • 11
    Yuille MR,Matutes E,Marossy A,Hilditch B,Catovsky D,Houlston RS. Familial chronic lymphocytic leukaemia: a survey and review of published studies. Br J Haematol 2000; 109: 7949.
  • 12
    Swift M,Reitnauer PJ,Morrell D,Chase CL. Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 1987; 316: 128994.
  • 13
    Rauscher GH,Sandler DP,Poole C,Pankow J,Mitchell B,Bloomfield CD,Olshan AF. Family history of cancer and incidence of acute leukemia in adults. Am J Epidemiol 2002; 156: 51726.
  • 14
    Bouchardy C. Switzerland, Geneva. In: ParkinDM,WhelanSL,FerlayJ,RaymondL,YoungJ, eds. Cancer incidence in five continents, Vol. 7. Lyon: International Agency for Research on Cancer, 1997. 6669.
  • 15
    World Health Organization (WHO), eds. ICD-O International classification of diseases for oncology, 1st ed. Geneva: World Health Organization, 1976.
  • 16
    Bouchardy C,Verkooijen HM,Chappuis PO,Vlastos G,Schäfer P,Kurtz J,Benhamou S,Sappino AP. Occurrence and impact of genetic factors in breast cancer among the female population in Geneva: creation of the Geneva familial breast cancer registry. Bull Suisse Cancer 2002; 2650: 1658.
  • 17
    Hampel H,Sweet K,Westman JA,Offit K,Eng C. Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet 2004; 41: 8191.
  • 18
    SobinLH, WittekindCh, eds. TNM classification of malignant tumours,6th ed. New York: UICC, 2002.
  • 19
    Coleman MP,Hermon C,Douglas A. Person-Years (PYRS). A Fortran program for cohort study analysis. Lyon: International Agency for Research on Cancer (IARC), 1989. Report No. 89/006.
  • 20
    Verkooijen HM,Chappuis PO,Rapiti E,Vlastos G,Fioretta G,Sarp S,Sappino AP,Schubert H,Bouchardy C. Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study. Br J Cancer 2006; 94: 2318.
  • 21
    Rudd MF,Sellick GS,Webb EL,Catovsky D,Houlston RS. Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia. Blood 2006; 108: 63844.
  • 22
    Rauscher GH,Sandler DP,Poole C,Pankow J,Shore D,Bloomfield CD,Olshan AF. Is family history of breast cancer a marker of susceptibility to exposures in the incidence of de novo adult acute leukemia? Cancer Epidemiol Biomarkers Prev 2003; 12: 28994.